MedPath

葆元生物医药科技(杭州)有限公司

Ownership
-
Established
2018-11-27
Employees
-
Market Cap
-
Website
http://anhearttherapeutics.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Taletrectinib Adipate Capsules

Product Name
达伯乐
Approval Number
国药准字H20240044
Approval Date
Dec 17, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.